Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.

Aktionärsstruktur

Inhaber in %
Freefloat 99.73
The Vanguard Group, Inc. 9.16
Vanguard Group, Inc. (Subfiler) 8.72
SSgA Funds Management, Inc. 5.52
State Street Corp. 5.51
Vanguard Total Stock Market ETF 3.14
BlackRock Fund Advisors 3.03
PRIMECAP Management Co. 2.73
Vanguard 500 Index Fund 2.47
Geode Capital Management LLC 2.31
BlackRock Institutional Trust Co. NA 2.28
Charles Schwab Investment Management, Inc. 1.94
Invesco QQQ Trust 1.87
Vanguard PRIMECAP Fund 1.67
Morgan Stanley Smith Barney LLC 1.48

*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.

Personal

2019 2020 2021 2022 2023
Personal am Ende des Jahres 23'400 24'300 24'200 25'200 26'700
Umsatz pro Mitarbeiter in Mio. EUR 0.99 1.04 1.07 1.04 1.05

Bilanz (in Mio. EUR) - Aktiva

2019 2020 2021 2022 2023
Summe Umlaufvermögen 18'440 21'144 19'385 22'186 30'332
Summe Anlagevermögen 40'104 42'854 40'679 43'301 71'655
Summe Aktiva 59'707 62'948 61'165 65'121 97'154

Bilanz (in Mio. EUR) - Passiva

2019 2020 2021 2022 2023
Gesamtverschuldung/ -verbindlichkeiten 30'431 33'445 33'979 39'640 65'423
Summe Fremdkapital 50'034 53'539 54'465 61'460 90'922
Summe Eigenkapital 9'673 9'409 6'700 3'661 6'232
Summe Passiva 59'707 62'948 61'165 65'121 97'154

Adresse

One Amgen Center Drive, 91320-1799 Thousand Oaks
Telefon +1 (805) 447-1000
Fax +1 (805) 447-1010
URL http://www.amgen.com

Management

Amy E. Miles
Independent Director
Brian J. Druker
Independent Director
Charles M. Holley
Independent Director
Darryl Sleep
Chief Medical Officer & Senior VP-Global Medical
David A. Piacquad
Senior Vice President
David M. Reese
Chief Technology Officer & Executive VP
Derek Miller
Chief Human Resources Officer
Ellen Jamison Kullman
Independent Director
Esteban Santos
Executive Vice President-Operations
Greg C. Garland
Independent Director
James E. Bradner
Chief Scientific Officer
Jean-Charles Soria
SVP-Research and Development
Jonathan P. Graham
Secretary, Executive VP & General Counsel
Judy L. Brown
Senior Vice President-Corporate Affairs
Linda H. Louie
Chief Accounting Officer & Vice President-Finance
Linda H. Louie
Vice President-Finance
Lori A. Johnston
Executive Vice President
Mark J. Taisey
Senior VP-Global Regulatory Affairs & Strategy
Matthew C. Busch
Chief Accounting Officer & Vice President-Finance
Michael V. Drake
Independent Director
Mike Zahigian
Chief Information Officer & Senior Vice President
Murdo J. Gordon
EVP-Global Commercial Operations
Nancy A. Grygiel
Chief Compliance Officer
Omar Syed Ishrak
Independent Director
Paul Burton
Chief Medical Officer
Peter H. Griffith
Chief Financial Officer & Executive Vice President
Rachna Khosla
Senior Vice President-Business Development
Robert A. Bradway
Chairman, President & Chief Executive Officer
Robert A. Eckert
Lead Independent Director
Robert Sanders Williams
Independent Director
Robert T. Fremeau
Scientific Director
Ronald D. Sugar
Independent Director
Susan Sweeney
Senior VP-Global Marketing, Access & Capabilities
Tyler E. Jacks
Independent Director
Victoria H. Blatter
Senior Vice President-Global Government Affairs
Wanda M. Austin
Independent Director

Eintrag hinzufügen

Erfolgreich hinzugefügt!. Zu Portfolio/Watchlist wechseln.

Es ist ein Fehler aufgetreten!

Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben. Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.

CHF
Hinzufügen